{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:17:14Z","timestamp":1793139434357,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.semradonc.2025.02.011","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T07:15:52Z","timestamp":1741936552000},"page":"271-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Oral Mucositis in Head and Neck Cancer Patients"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5036-8389","authenticated-orcid":false,"given":"Carryn","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semradonc.2025.02.011_bib0001","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3322\/caac.21704","article-title":"The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies","volume":"72","author":"Elad","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"10.1016\/j.semradonc.2025.02.011_bib0002","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.oraloncology.2009.08.006","article-title":"Mucositis: the impact, biology and therapeutic opportunities of oral mucositis","volume":"45","author":"Sonis","year":"2009","journal-title":"Oral Oncol"},{"issue":"20","key":"10.1016\/j.semradonc.2025.02.011_bib0003","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1200\/JCO.2010.32.4103","article-title":"Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial","volume":"29","author":"Henke","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9 Suppl","key":"10.1016\/j.semradonc.2025.02.011_bib0004","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","article-title":"Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients","volume":"100","author":"Sonis","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.semradonc.2025.02.011_bib0005","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijrobp.2007.01.053","article-title":"Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies","volume":"68","author":"Elting","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2025.02.011_bib0006","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2147\/JPR.S247472","article-title":"Nerve growth factor signaling and its contribution to pain","volume":"13","author":"Barker","year":"2020","journal-title":"J Pain Res"},{"issue":"10","key":"10.1016\/j.semradonc.2025.02.011_bib0007","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/cncr.23898","article-title":"Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life","volume":"113","author":"Elting","year":"2008","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.semradonc.2025.02.011_bib0008","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000487085","article-title":"Burden of oral mucositis: a systematic review and implications for future research","volume":"41","author":"Berger","year":"2018","journal-title":"Oncol Res Treat"},{"issue":"53","key":"10.1016\/j.semradonc.2025.02.011_bib0009","doi-asserted-by":"crossref","first-page":"lgz010","DOI":"10.1093\/jncimonographs\/lgz010","article-title":"Costs of oral complications of cancer therapies: estimates and a blueprint for future study","volume":"2019","author":"Elting","year":"2019","journal-title":"JNCI Monographs"},{"key":"10.1016\/j.semradonc.2025.02.011_bib0010","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"126","author":"Elad","year":"2020","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.semradonc.2025.02.011_bib0011","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.oraloncology.2006.03.014","article-title":"Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers","volume":"43","author":"Sonis","year":"2007","journal-title":"Oral Oncol"},{"issue":"4","key":"10.1016\/j.semradonc.2025.02.011_bib0012","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc1318","article-title":"The pathobiology of mucositis","volume":"4","author":"Sonis","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"22","key":"10.1016\/j.semradonc.2025.02.011_bib0013","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1016\/S0021-9258(18)63504-5","article-title":"Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)","volume":"244","author":"McCord","year":"1969","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.semradonc.2025.02.011_bib0014","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.3390\/cancers13235902","article-title":"Is there an interplay between oral microbiome, head and neck carcinoma and radiation-induced oral mucositis?","volume":"13","author":"Gugnacki","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.semradonc.2025.02.011_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2023.106488","article-title":"Influence of the microbiome on radiotherapy-induced oral mucositis and its management: A comprehensive review","volume":"144","author":"Fern\u00e1ndez Forn\u00e9","year":"2023","journal-title":"Oral Oncol"},{"issue":"10","key":"10.1016\/j.semradonc.2025.02.011_bib0016","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1007\/s00520-019-04890-2","article-title":"Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines","volume":"27","author":"Zadik","year":"2019","journal-title":"Supp Care Cancer"},{"issue":"2","key":"10.1016\/j.semradonc.2025.02.011_bib0017","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.radonc.2013.08.010","article-title":"Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation","volume":"109","author":"Antunes","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2025.02.011_bib0018","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.oraloncology.2015.10.022","article-title":"Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation","volume":"52","author":"Antunes","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.semradonc.2025.02.011_bib0019","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.oraloncology.2016.01.005","article-title":"Could the biological robustness of low level laser therapy (photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients","volume":"54","author":"Sonis","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.semradonc.2025.02.011_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.oraloncology.2019.04.004","article-title":"Tumor safety and side effects of photobiomodulation therapy used for prevention and management of cancer treatment toxicities. A systematic review","volume":"93","author":"de Pauli Paglioni","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.semradonc.2025.02.011_bib0021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.oraloncology.2017.05.018","article-title":"Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis","volume":"71","author":"Antunes","year":"2017","journal-title":"Oral Oncol"},{"issue":"16 suppl","key":"10.1016\/j.semradonc.2025.02.011_bib0022","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1200\/JCO.2022.40.16_suppl.6005","article-title":"ROMAN: phase 3 trial of avasopasem manganese (GC4419) for severe oral mucositis (SOM) in patients receiving chemoradiotherapy (CRT) for locally advanced, nonmetastatic head and neck cancer (LAHNC)","volume":"40","author":"Anderson","year":"2022","journal-title":"JCO"},{"key":"10.1016\/j.semradonc.2025.02.011_bib0023","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.ijrobp.2022.07.518","article-title":"Tumor outcomes for ROMAN: phase 3 trial of Avasopasem Manganese (GC4419) for severe oral mucositis (SOM) in patients receiving chemoradiotherapy (CRT) for locally advanced head and Neck cancer (LAHNC)","volume":"114","author":"Anderson","year":"2022","journal-title":"Int J Rad Oncol Bio Phys"},{"issue":"10166","key":"10.1016\/j.semradonc.2025.02.011_bib0024","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semradonc.2025.02.011_bib0025","article-title":"Benefit of avasopasem manganese on severe oral mucositis in head and neck cancer in the ROMAN trial: unplanned secondary analysis","volume":"10","author":"Anderson","year":"2024","journal-title":"Advanc Radiat Oncol"},{"issue":"3","key":"10.1016\/j.semradonc.2025.02.011_bib0026","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/j.ijrobp.2021.07.325","article-title":"A phase 1-2 trial of concurrent radiation therapy cisplatin, nd BMX-001 in locally advanced head and neck cancer","volume":"111","author":"Brizel","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2025.02.011_bib0027","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1200\/JCO.23.00837","article-title":"Streptococcus salivarius K12 alleviates oral mucositis in patients undergoing radiotherapy for malignant head and neck tumors: A randomized controlled trial","volume":"42","author":"Peng","year":"2024","journal-title":"JCO"},{"key":"10.1016\/j.semradonc.2025.02.011_bib0028","series-title":"Soligenix Announces Topline Results from Its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients","year":"2020"},{"key":"10.1016\/j.semradonc.2025.02.011_bib0029","series-title":"Monopar Announces Result of Interim Analysis of Phase 2b\/3 Trial Evaluating Validive for Severe Oral Mucositis","year":"2023"},{"issue":"12","key":"10.1016\/j.semradonc.2025.02.011_bib0030","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.oraloncology.2009.08.006","article-title":"Mucositis: the impact, biology and therapeutic opportunities of oral mucositis","volume":"45","author":"Sonis","year":"2009","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.semradonc.2025.02.011_bib0031","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13014-023-02317-1","article-title":"Proton therapy and oral mucositis in oral & oropharyngeal cancers: outcomes, dosimetric and NTCP benefit","volume":"18","author":"Nangia","year":"2023","journal-title":"Radiat Oncol"},{"issue":"1107","key":"10.1016\/j.semradonc.2025.02.011_bib0032","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190955","article-title":"Reduced radiation-induced toxicity by using proton therapy for the treatment of oropharyngeal cancer","volume":"93","author":"Meijer","year":"2020","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1016\/j.semradonc.2025.02.011_bib0033","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2015.12.008","article-title":"Proton bean radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors","volume":"118","author":"Romesser","year":"2016","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.semradonc.2025.02.011_bib0034","first-page":"579","article-title":"A longitudinal metagenomics comparative analysis of oral microbiome shifts in patients receiving proton radiation versus photon radiation for head and neck cancer","volume":"10","author":"Meiller","year":"2024","journal-title":"J Cancer Allied Spec"},{"issue":"16 suppl","key":"10.1016\/j.semradonc.2025.02.011_bib0035","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1200\/JCO.2024.42.16_suppl.6006","article-title":"Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of head and neck oropharyngeal carcinoma (OPC)","volume":"42","author":"Frank","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2025.02.011_bib0036","series-title":"RePORTER ARMOR Trial","year":"2021"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429625000165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429625000165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T07:54:31Z","timestamp":1741938871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429625000165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1053429625000165"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2025.02.011","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Mucositis in Head and Neck Cancer Patients","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2025.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}